Introduction: Extracorporeal shock wave lithotripsy (ESWL) is an option for the treatment of urinary lithiasis. Objective: To describe the outcomes of ESWL for the treatment of urinary lithiasis in children. Methods: A descriptive and retrospective study of 51 patients with urinary lithiasis that underwent ESWL from 2014 to 2019. Results: Males and 15–18-year-old patients prevailed; 27.4% had prior surgery; 10-20 mm lithiasis of renal location and density between 400-799 HU were the most common; a double J stent was the most utilized urinary derivation prior to lithotripsy treatment; 7.8% required retreatment; 13.7% additional interventions; the stone-free rate was 74.5% at one month and 92.2% at three months. The size of the lithiasis was associated with the success of the treatment (p<0.023). The most frequent complication was steinstrasse; endourologic procedures were the most utilized, grade III b (Clavien-Dindo) prevailed and were associated to older patients (p=0.04), renal lithiasis localization (p=0.017), larger size (p=0.08), and density(p=0.036). Conclusions: ESWL is effective and safe for treating urinary lithiasis in children. Its success was significantly associated to smaller stone size and its complications to patients of older age, larger stone size, density and renal localization of the lithiasis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.